Literature DB >> 18642969

Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Zheng Huang1, Heping Xu, Arlen D Meyers, Ali I Musani, Luowei Wang, Randall Tagg, Al B Barqawi, Yang K Chen.   

Abstract

Photodynamic therapy (PDT) involves the administration of photosensitizer followed by local illumination with visible light of specific wavelength(s). In the presence of oxygen molecules, the light illumination of photosensitizer can lead to a series of photochemical reactions and consequently the generation of cytotoxic species. The quantity and location of PDT-induced cytotoxic species determine the nature and consequence of PDT. Much progress has been seen in both basic research and clinical application in recent years. Although the majority of approved PDT clinical protocols have primarily been used for the treatment of superficial lesions of both malignant and non-malignant diseases, interstitial PDT for the ablation of deep-seated solid tumors are now being investigated worldwide. The complexity of the geometry and non-homogeneity of solid tumor pose a great challenge on the implementation of minimally invasive interstitial PDT and the estimation of PDT dosimetry. This review will discuss the recent progress and technical challenges of various forms of interstitial PDT for the treatment of parenchymal and/or stromal tissues of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642969      PMCID: PMC2593637          DOI: 10.1177/153303460800700405

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  104 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 2.  The future of photodynamic therapy in oncology.

Authors:  Ron R Allison; Vanderlei S Bagnato; Rosa Cuenca; Gordon H Downie; Claudio H Sibata
Journal:  Future Oncol       Date:  2006-02       Impact factor: 3.404

3.  Advances in photodynamic therapy for the treatment of head and neck cancers.

Authors:  M Biel
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

4.  Photodynamic therapy of brain tumors--a work in progress.

Authors:  Paul J Muller; Brian C Wilson
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

5.  Photodynamic therapy for prostate cancer: One urologist's perspective.

Authors:  Steven H Selman
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-11-13       Impact factor: 3.631

6.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Authors:  B W Henderson; T M Busch; L A Vaughan; N P Frawley; D Babich; T A Sosa; J D Zollo; A S Dee; M T Cooper; D A Bellnier; W R Greco; A R Oseroff
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

7.  Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours.

Authors:  Josephine H Woodhams; Alexander J MacRobert; Marco Novelli; Stephen G Bown
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

8.  Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration.

Authors:  Kimberley S Samkoe; Aisling A Clancy; Aliaksandr Karotki; Brian C Wilson; David T Cramb
Journal:  J Biomed Opt       Date:  2007 May-Jun       Impact factor: 3.170

9.  Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy.

Authors:  Eduardo H Moriyama; Stuart K Bisland; Lothar Lilge; Brian C Wilson
Journal:  Photochem Photobiol       Date:  2004 Sep-Oct       Impact factor: 3.421

10.  Indirect fluorescence laryngoscopy in the diagnosis of precancerous and cancerous laryngeal lesions.

Authors:  C Arens; D Reussner; J Woenkhaus; A Leunig; C S Betz; H Glanz
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-10       Impact factor: 3.236

View more
  74 in total

1.  In-body optical stimulation formed connective tissue vascular grafts, "biotubes," with many capillaries and elastic fibers.

Authors:  Tomonori Oie; Masashi Yamanami; Hatsue Ishibashi-Ueda; Keiichi Kanda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2010-09-30       Impact factor: 1.731

2.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

3.  Characterizing low fluence thresholds for in vitro photodynamic therapy.

Authors:  Brad A Hartl; Henry Hirschberg; Laura Marcu; Simon R Cherry
Journal:  Biomed Opt Express       Date:  2015-02-10       Impact factor: 3.732

4.  Optical lens-microneedle array for percutaneous light delivery.

Authors:  Moonseok Kim; Jeesoo An; Ki Su Kim; Myunghwan Choi; Matjaž Humar; Sheldon J J Kwok; Tianhong Dai; Seok Hyun Yun
Journal:  Biomed Opt Express       Date:  2016-09-21       Impact factor: 3.732

Review 5.  Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.

Authors:  Nela Malatesti; Ivana Munitic; Igor Jurak
Journal:  Biophys Rev       Date:  2017-03-24

6.  Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats.

Authors:  Takayo Miyakogawa; Genta Kanai; Ryoko Tatsumi; Hiroo Takahashi; Kaichiro Sawada; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2016-10-18       Impact factor: 2.801

7.  Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible?

Authors:  Luo-Wei Wang; Li-Bo Li; Zhao-Shen Li; Yang K Chen; Fred W Hetzel; Zheng Huang
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

8.  Classification of Metal-based Drugs According to Their Mechanisms of Action.

Authors:  Eszter Boros; Paul J Dyson; Gilles Gasser
Journal:  Chem       Date:  2019-11-07       Impact factor: 22.804

9.  Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy.

Authors:  Peng Huang; Jing Lin; Shouju Wang; Zhijun Zhou; Zhiming Li; Zhe Wang; Chunlei Zhang; Xuyi Yue; Gang Niu; Min Yang; Daxiang Cui; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2013-03-22       Impact factor: 12.479

10.  Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Authors:  Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2009-11-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.